RESMED INC (RMD) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for RESMED INC (RMD): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 67/100 — a percentile rank of RESMED INC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $31.9B |
| P / E | 20.9× |
| P / S | 5.6× |
| EV / EBITDA | 14.7× |
| Gross margin | 61.6% |
| Operating margin | 33.4% |
| Net margin | 26.9% |
| Return on equity | 23.1% |
| ROIC | 25.9% |
| Revenue growth | 9.9% |
| Debt / equity | 0.1× |
| Dividend yield | 1.1% |
Is RESMED INC overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from RESMED INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact